Pathology reports are written for clinicians. Patients often receive them at a stressful moment and search for one word -- "malignant," "aggressive," "clear margins." That approach increases anxiety and reduces understanding.
A better approach is to read pathology as a structured document.
1. Diagnosis: what is the tumor, exactly?
This is the most important line. It usually includes histologic type, invasive vs in situ, and primary vs metastatic.
2. Grade: how aggressive does it look?
Grade describes how abnormal tumor cells appear and often correlates with behavior.
3. Size and extent: how far did it go locally?
Look for tumor size, depth of invasion, and extension into adjacent structures.
4. Margins: was tumor at the cut edge?
Margins are often described as "negative" or "positive." A positive margin is tumor touching ink.
5. Lymphovascular invasion (LVI) and perineural invasion (PNI)
These features can correlate with higher risk patterns and may influence adjuvant treatment decisions.
6. Lymph nodes: how many were examined and involved?
Look for number examined, number positive, and extranodal extension.
7. Biomarkers: what does the tumor express?
Biomarkers differ by cancer type. The key is understanding what the marker changes in treatment options.
8. TNM elements: the staging language
Pathology contributes to staging, but imaging and clinical context also matter.
When to consider a second pathology review
- When the tumor behaves differently than the report suggests
- When treatment options depend heavily on subtype or biomarkers
- When the sample is small or borderline
- When there are conflicting reports
A pathology report is not a verdict. It is a structured input into a larger decision system. Understanding the key sections reduces fear and improves the quality of conversations with your treating team.